Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Apogee Therapeutics Inc (NASDAQ: APGE) was $39.58 for the day, up 6.14% from the previous closing price of $37.29. In other words, the price has increased by $6.14 from its previous closing price. On the day, 0.71 million shares were traded.
Ratios:
Our analysis of APGE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 15.82 and its Current Ratio is at 15.82. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on March 13, 2025, initiated with a Buy rating and assigned the stock a target price of $95.
On November 25, 2024, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $89.
On May 10, 2024, BofA Securities started tracking the stock assigning a Buy rating and target price of $80.BofA Securities initiated its Buy rating on May 10, 2024, with a $80 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 07 ’25 when Dambkowski Carl sold 2,725 shares for $35.75 per share. The transaction valued at 97,419 led to the insider holds 244,448 shares of the business.
Dambkowski Carl sold 3,860 shares of APGE for $139,801 on Apr 02 ’25. The Chief Medical Officer now owns 247,173 shares after completing the transaction at $36.22 per share. On Apr 02 ’25, another insider, CARL DAMBKOWSKI, who serves as the Officer of the company, bought 9,310 shares for $35.61 each.
Stock Price History:
Over the past 52 weeks, APGE has reached a high of $63.50, while it has fallen to a 52-week low of $26.20. The 50-Day Moving Average of the stock is 8.68%, while the 200-Day Moving Average is calculated to be -11.20%.
Shares Statistics:
A total of 46.04M shares are outstanding, with a floating share count of 36.22M. Insiders hold about 37.94% of the company’s shares, while institutions hold 82.25% stake in the company.
